Clinical Trial Update: Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a new anti-cancer immunotherapy in adults with acute myeloid leukemia who had suboptimal response to induction chemotherapy; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Leukaemia, Myelocytic, Acute | Phase 1 | Status: COMPLETED | Results posted: 2018-11-29